83 FR 2167 - Advisory Council on Alzheimer's Research, Care, and Services; Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 10 (January 16, 2018)

This notice announces the public meeting of the Advisory Council on Alzheimer's Research, Care, and Services (Advisory Council). The Advisory Council on Alzheimer's Research, Care, and Services provides advice on how to prevent or reduce the burden of Alzheimer's disease and related dementias on people with the disease and their caregivers. During the January meeting, the Research Subcommittee will be taking charge of the theme, focusing on the process from targets to treatments. The Council will hear speakers on the preclinical pipeline, the clinical trial pipeline, and the industry perspective. The meeting will also include discussion of a driver diagram to guide the Council's future work, updates and a report from the October Care Summit, and federal workgroup updates.

[Federal Register Volume 83, Number 10 (Tuesday, January 16, 2018)]
[Notices]
[Page 2167]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-00480]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Advisory Council on Alzheimer's Research, Care, and Services; 
Meeting

AGENCY: Assistant Secretary for Planning and Evaluation, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the public meeting of the Advisory 
Council on Alzheimer's Research, Care, and Services (Advisory Council). 
The Advisory Council on Alzheimer's Research, Care, and Services 
provides advice on how to prevent or reduce the burden of Alzheimer's 
disease and related dementias on people with the disease and their 
caregivers. During the January meeting, the Research Subcommittee will 
be taking charge of the theme, focusing on the process from targets to 
treatments. The Council will hear speakers on the preclinical pipeline, 
the clinical trial pipeline, and the industry perspective. The meeting 
will also include discussion of a driver diagram to guide the Council's 
future work, updates and a report from the October Care Summit, and 
federal workgroup updates.

DATES: The meeting will be held on January 26, 2018 from 9:00 a.m. to 
5:00 p.m. EDT.

ADDRESSES: The meeting will be held in Room 800 in the Hubert H. 
Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201.
    Comments: Time is allocated in the afternoon on the agenda to hear 
public comments. The time for oral comments will be limited to two (2) 
minutes per individual. In lieu of oral comments, formal written 
comments may be submitted for the record to Rohini Khillan, OASPE, 200 
Independence Avenue SW, Room 424E, Washington, DC 20201. Comments may 
also be sent to [email protected]. Those submitting written comments should 
identify themselves and any relevant organizational affiliations.

FOR FURTHER INFORMATION CONTACT: 
    Rohini Khillan (202) 690-5932, [email protected]. Note: 
Seating may be limited. Those wishing to attend the meeting must send 
an email to [email protected] and put ``January 26 Meeting Attendance'' in 
the Subject line by Tuesday, January 16, so that their names may be put 
on a list of expected attendees and forwarded to the security officers 
at the Department of Health and Human Services. Any interested member 
of the public who is a non-U.S. citizen should include this information 
at the time of registration to ensure that the appropriate security 
procedure to gain entry to the building is carried out. Although the 
meeting is open to the public, procedures governing security and the 
entrance to Federal buildings may change without notice. If you wish to 
make a public comment, you must note that within your email.

SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the 
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and 
(a)(2)). Topics of the Meeting: During the January meeting, the 
Research Subcommittee will be taking charge of the theme, focusing on 
the process from targets to treatments. The Council will hear speakers 
on the preclinical pipeline, the clinical trial pipeline, and the 
industry perspective. The meeting will also include discussion of a 
driver diagram to guide the Council's future work, updates and a report 
from the October Care Summit, and federal workgroup updates.
    Procedure and Agenda: This meeting is open to the public. Please 
allow 30 minutes to go through security and walk to the meeting room. 
The meeting will also be webcast at www.hhs.gov/live.

    Authority:  42 U.S.C. 11225; Section 2(e)(3) of the National 
Alzheimer's Project Act. The panel is governed by provisions of 
Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets 
forth standards for the formation and use of advisory committees.

    Dated: January 9, 2018.
John R. Graham,
Acting Assistant Secretary for Planning and Evaluation.
[FR Doc. 2018-00480 Filed 1-12-18; 8:45 am]
 BILLING CODE 4150-05-P